High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$180K
$180,000
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
CRNX
M
Crinetics Pharmaceuticals, Inc.
Struthers Richard Scott
• CEO
Equity Compensation
2025-12-18
$585,890x4
|
||||||
| CRNX |
Crinetics Pharmaceuticals, Inc.
|
CEO
Equity Compensation
|
2025-12-18 | $585,890x4 | M | Form 4 |
|
CRNX
S
Crinetics Pharmaceuticals, Inc.
Struthers Richard Scott
• CEO
10b5-1 Sell
2025-09-26
$180,000
|
||||||
| CRNX |
Crinetics Pharmaceuticals, Inc.
|
CEO
10b5-1 Sell
|
2025-09-26 | $180,000 | S | Form 4 |